Cloud Genomics Market Report 2025

The cloud genomics market size has grown exponentially in recent years. It will grow from $3.17 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 23.3%. The growth observed during the historic period can be linked to the expansion of biobank initiatives, increasing research in cancer genomics, rising adoption of cloud solutions for data storage, greater use of cloud computing in healthcare, and growing interest in population health management.

The cloud genomics market size is expected to see exponential growth in the next few years. It will grow to $8.93 billion in 2029 at a compound annual growth rate (CAGR) of 23%. The growth projected for the forecast period can be attributed to the advancement of precision medicine, rising prevalence of genetic disorders, increasing public awareness of genetic health risks, wider availability of direct-to-consumer genomic testing, and enhanced government funding for genomic research. Key trends during the forecast period include improvements in sequencing technologies, integration of artificial intelligence, collaboration between public and private sectors, incorporation with electronic health records, and advancements in bioinformatics tools.

The growing investments in genomics research are expected to drive the expansion of the cloud genomics market. Genomics research involves analyzing the complete DNA sequence of organisms to understand gene functions, interactions, and their role in biological processes. The increasing investments in this field are mainly due to the potential of genomics to enable personalized medicine, which allows for more precise diagnoses and targeted treatments based on an individual’s genetic profile. The rising volume of genomic data from these studies necessitates scalable, cost-effective cloud infrastructure for storage and analysis. For example, in December 2022, the UK Department of Health and Social Care announced a £105 million investment to fast-track the diagnosis of rare genetic conditions in newborns. This funding aims to provide critical, life-saving treatments through genomic research. Consequently, the growing focus on genomics research is fueling the demand for cloud genomics solutions.

Companies in the cloud genomics market are developing advanced software solutions, such as software accelerators, to speed up the development and deployment of complex applications. Software accelerators enhance the performance of software by optimizing data processing and computational tasks. For instance, in January 2023, QIAGEN Digital Insights launched the QIAGEN CLC Genomics Workbench Premium. This tool addresses the data analysis challenges associated with next-generation sequencing (NGS) by providing faster analysis of whole genome sequencing (WGS), whole exome sequencing (WES), and large panel sequencing data. It features LightSpeed technology, a software accelerator that converts raw sequencing data into interpretable genetic variant lists with remarkable speed. This tool enables labs to perform whole genome sequencing at a cost of around $1 per genome, using cloud infrastructure to enhance efficiency and scalability.

In May 2025, QIAGEN, a Netherlands-based company specializing in molecular diagnostics tools, acquired Genoox for $80 million to enhance its AI-powered genomic interpretation capabilities. This acquisition strengthens QIAGEN’s Digital Insights portfolio, helping to provide scalable, cloud-based decision-support tools to clinical labs. Genoox, a US-based company, specializes in cloud genomics and will help QIAGEN further advance its AI-driven solutions for genomic data interpretation.

Major players in the cloud genomics market are Microsoft Corp., Amazon Web Services Inc., F. Hoffmann-La Roche Ltd., IBM Corporation, Oracle Corporation, Thermo Fisher Scientific Inc., Illumina Inc., PerkinElmer Inc., Qiagen N.V., Element Biosciences Inc., Human Longevity Inc., Seven Bridges Genomics, DNAnexus Inc., Lifebit Biotech Ltd., Fabric Genomics Inc., PierianDx Inc., Veritas Genetics Inc., WuXi, NantOmics LLC, Saphetor SA, Nebula Genomics, Gene by Gene Ltd., Nucleome Therapeutics.

North America was the largest region in the cloud genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cloud genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cloud genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Cloud genomics refers to the use of cloud computing technologies to manage and analyze large volumes of genomic data. It provides scalable storage and high-performance computing capabilities, enabling researchers to efficiently process the vast amounts of genetic information generated by sequencing technologies.

The primary components of cloud genomics include software, hardware, and services. Software consists of cloud-based platforms, applications, and analytical tools used to store, process, and interpret genomic data. Deployment options include public cloud, private cloud, and hybrid cloud solutions. Cloud genomics is applied in areas such as clinical diagnostics, drug discovery and development, personalized medicine, and research. Key end users include hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, and other related organizations.

The cloud genomics market research report is one of a series of new reports that provides cloud genomics market statistics, including cloud genomics industry global market size, regional shares, competitors with a cloud genomics market share, detailed cloud genomics market segments, market trends and opportunities, and any further data you may need to thrive in the cloud genomics industry. This cloud genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cloud genomics market consists of revenues earned by entities by providing services such as genome data storage, sequence data analysis, collaborative data sharing, and data security services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloud genomics market also includes sales of high-throughput DNA sequencers, storage arrays, GPU-based accelerators, and data transfer appliances. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.